3Chopt Investment Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.13M Buy
24,198
+2,004
+9% +$235K 0.59% 37
2026
Q1
$2.69M Buy
22,194
+676
+3% +$78K 0.62% 39
2025
Q4
$2.28M Sell
21,518
-795
-4% -$74.6K 0.51% 47
2025
Q3
$1.89M Sell
22,313
-11,839
-35% -$975K 0.43% 57
2025
Q2
$2.73M Sell
34,152
-2,848
-8% -$226K 0.66% 38
2025
Q1
$3.35M Sell
37,000
-131
-0.4% -$12.2K 0.88% 27
2024
Q4
$3.72M Buy
37,131
+1,969
+6% +$203K 1.28% 16
2024
Q3
$4.02M Buy
35,162
+641
+2% +$76.2K 1.44% 15
2024
Q2
$4.3M Buy
34,521
+79
+0.2% +$10.2K 1.31% 13
2024
Q1
$4.57M Buy
34,442
+371
+1% +$45.7K 1.88% 9
2023
Q4
$3.74M Buy
34,071
+586
+2% +$60.8K 1.38% 10
2023
Q3
$3.47M Buy
33,485
+486
+1% +$52.4K 2.05% 9
2023
Q2
$3.83M Sell
32,999
-1,281
-4% -$145K 1.92% 9
2023
Q1
$3.67M Buy
34,280
+27
+0.1% +$2.92K 1.96% 8
2022
Q4
$3.83M Buy
+34,253
New +$3.5M 2.09% 6

Other funds holding MRK

3Chopt Investment Partners's MRK Position: Q2 2026 in Review

3Chopt Investment Partners increased its Merck (MRK) stake by 9% in Q2 2026, buying an estimated $235K and bringing the position to 24,198 shares worth $3.13M. The position accounts for 0.59% of the portfolio, ranked #37.

3Chopt Investment Partners first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $4.57M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • 3Chopt Investment Partners held 24,198 shares of Merck worth $3.13M as of Q2 2026.
  • 3Chopt Investment Partners bought 2,004 Merck shares in Q2 2026, an estimated $235K.
  • Merck made up 0.59% of 3Chopt Investment Partners's portfolio in Q2 2026, its #37 holding.
  • 3Chopt Investment Partners first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • 3Chopt Investment Partners's Merck position peaked at $4.57M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on 3Chopt Investment Partners's 13F filing for Q2 2026, filed 29 Jul 2026.